Announce Date | 05/08/2025 |
EPS Normalized Actual | $0.04 In Line |
EPS GAAP Actual | $0.04 In Line |
Revenue Actual | $22.4974B |
Revenue Surprise | Beat by $22497.4M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.24994 |
EPS GAAP Estimate | $0.24994 |
Revenue Estimate | $54.9703935B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.69942 | 1.45 | 1.61719 | 1.78473 | 1 |
Dec 2028 | 1.31077 | 1.88 | 1.228 | 1.3761 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.24 | 0.03982 | 22.4974B | 9.87% | 3253.87M |
FQ4 2024 (Dec 2024) | 0.31 | 0.05695 | 27.0354B | 26.06% | 5987.31M |
FQ3 2024 (Sep 2024) | 0.22 | -1.32141 | 22.0967B | 6.83% | -19078.5M |
FQ2 2024 (Jun 2024) | 0.15 | -1.19259 | 20.0442B | 5.72% | -15984.1M |
FQ1 2024 (Mar 2024) | 0.23 | 0.18 | 20.2763B | -1.26% | 4156.29M |
FQ4 2023 (Dec 2023) | 0.28 | 0.28 | 19.9892B | -13.53% | 19989.2M |
FQ3 2023 (Sep 2023) | 0.2 | 0.2 | 20.5876B | 0% | 20587.6M |
FQ2 2023 (Jun 2023) | 0.16 | 0.16 | 18.8981B | 100% | 18898.1M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.24994
Consensus Revenue Estimates
54.9703935B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
FQ4 2026 (Dec 2026) | 0.32026 | -- | 0.30692 | 0.33582 | 0 |
FQ3 2026 (Sep 2026) | 0.30031 | -- | 0.29461 | 0.30601 | 0 |
FQ2 2026 (Jun 2026) | 0.2365 | -- | 0.23201 | 0.24099 | 0 |
FQ1 2026 (Mar 2026) | 0.21973 | -9.22 | 0.21058 | 0.23041 | 0 |
FQ4 2025 (Dec 2025) | 0.28131 | -10.2 | 0.26959 | 0.29498 | 2 |
FQ3 2025 (Sep 2025) | 0.24994 | 11.98 | 0.2486 | 0.25128 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 22.53B | -- | 22.53B | 22.53B | 1 |
FQ4 2026 (Dec 2026) | 23B | -- | 22.26B | 23.86B | 1 |
FQ3 2026 (Sep 2026) | 26.5B | -- | 26.12B | 26.89B | 0 |
FQ2 2026 (Jun 2026) | 25.8B | -- | 25.43B | 26.18B | 0 |
FQ1 2026 (Mar 2026) | 19.93B | -12.86 | 19.3B | 20.68B | 1 |
FQ4 2025 (Dec 2025) | 21.46B | -25.99 | 20.77B | 22.26B | 0 |
FQ3 2025 (Sep 2025) | 54.97B | 59.8 | 54.74B | 55.2B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.20018 | 0.24 | 0.03982 | 16.59% |
FQ4 2024 (Dec 2024) | 0.25305 | 0.31 | 0.05695 | 18.37% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.22 | -1.32141 | -600.64% |
FQ2 2024 (Jun 2024) | 1.34259 | 0.15 | -1.19259 | -795.06% |
FQ1 2024 (Mar 2024) | 0.05 | 0.23 | 0.18 | 78.26% |
FQ4 2023 (Dec 2023) | 0.28 | 0.28 | 100% | |
FQ3 2023 (Sep 2023) | 0.2 | 0.2 | 100% | |
FQ2 2023 (Jun 2023) | 0.16 | 0.16 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $19.24B | $22.5B | $3253.87M | 14.46% |
FQ4 2024 (Dec 2024) | $21.05B | $27.04B | $5987.31M | 22.15% |
FQ3 2024 (Sep 2024) | $41.18B | $22.1B | $-19078.5M | -86.34% |
FQ2 2024 (Jun 2024) | $36.03B | $20.04B | $-15984.1M | -79.74% |
FQ1 2024 (Mar 2024) | $16.12B | $20.28B | $4156.29M | 20.5% |
FQ4 2023 (Dec 2023) | $0B | $19.99B | $19989.2M | 100% |
FQ3 2023 (Sep 2023) | $0B | $20.59B | $20587.6M | 100% |
FQ2 2023 (Jun 2023) | $0B | $18.9B | $18898.1M | 100% |